Purple Biotech Ltd. (PPBT) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 6.78M | 9.87M | 10.77M | 6.31M | 7.52M | 8.91M | 6.94M | 7.86M | 11.4M | 15.79M | 16.72M | 19.38M |
| Cash & Short-Term Investments | 6.43M | 9.57M | 10.45M | 5.92M | 7.09M | 8.52M | 6.3M | 7.39M | 10.85M | 15.41M | 16.08M | 18.4M |
| Cash Only | 5.57M | 8.72M | 9.59M | 4.74M | 5.77M | 7.4M | 5.44M | 6.52M | 9.98M | 14.49M | 15.1M | 17.2M |
| Short-Term Investments | 859K | 856.99K | 862K | 1.18M | 1.32M | 1.12M | 862K | 867K | 869K | 923K | 980K | 1.2M |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 275K | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 353K | 292K | 320K | 394K | 428.01K | 109K | 638K | 473K | 548K | 171K | 634K | 984K |
| Total Non-Current Assets | 7.64M | 7.71M | 28.29M | 28.07M | 28.08M | 28.13M | 28.17M | 28.2M | 28.46M | 28.51M | 28.55M | 28.61M |
| Property, Plant & Equipment | 278K | 345.99K | 445K | 223K | 237K | 288K | 325K | 359K | 417K | 470K | 510K | 571K |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28.02M | 28.02M | 28.02M |
| Intangible Assets | 7.36M | 7.36M | 27.84M | 27.84M | 27.84M | 27.84M | 27.84M | 27.84M | 28.04M | 28.04K | 28.04K | 28.04K |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 14.42M | 17.57M | 39.06M | 34.38M | 35.59M | 37.04M | 35.1M | 36.06M | 39.86M | 44.3M | 45.27M | 48M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | -59.5% | -52.56% | 11.27% | -4.68% | -10.71% | -16.4% | -22.46% | -24.86% | -24.9% | -18.89% | -22.67% | -22.26% |
| Total Current Liabilities | 4.59M | 7.75M | 6.06M | 2.19M | 2.76M | 3.99M | 5.46M | 6.47M | 8.51M | 7.18M | 6.22M | 4.88M |
| Accounts Payable | 843K | 2.07M | 605K | 669K | 868.01K | 1.46M | 1.91M | 3.04M | 3.48M | 3.53M | 2.59M | 1.57M |
| Days Payables Outstanding | 2.02K | 2.31K | 1.01K | 1.46K | 2.34K | 3.87K | 4.65K | - | - | 1000K | - | - |
| Short-Term Debt | 0 | 244K | 207K | 0 | 137K | 183K | 184K | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.15M | 2.8M | 0 | 0 | 0 |
| Other Current Liabilities | 1.9M | 5.44M | 5.25M | 267K | 1.75M | 966K | 1.38M | 1.1M | 2.05M | 673K | 3.45M | 3.12M |
| Current Ratio | 1.48x | 1.27x | 1.78x | 2.88x | 2.72x | 2.23x | 1.27x | 1.22x | 1.34x | 2.20x | 2.69x | 3.98x |
| Quick Ratio | 1.48x | 1.27x | 1.78x | 2.88x | 2.72x | 2.23x | 1.27x | 1.22x | 1.34x | 2.20x | 2.69x | 3.98x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 160K | 160K | 189K | 140K | 140K | 140K | 179K | 220K | 262K | 2.82M | 333K | 378K |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 49K | 0 | 0 | 0 | 38K | 79K | 121K | 163K | 192K | 237K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 160K | 160K | 140K | 140K | 140K | 140K | 141K | 141K | 141K | 2.66M | 141K | 141K |
| Total Liabilities | 4.75M | 7.91M | 6.25M | 2.33M | 2.9M | 4.13M | 5.64M | 6.69M | 8.77M | 10.01M | 6.55M | 5.25M |
| Total Debt | 184K | 244K | 256K | 103K | 137K | 183K | 222K | 261K | 307K | 351K | 370K | 421K |
| Net Debt | -5.38M | -8.47M | -9.34M | -4.63M | -5.64M | -7.22M | -5.22M | -6.26M | -9.68M | -14.14M | -14.73M | -16.78M |
| Debt / Equity | 0.02x | 0.03x | 0.01x | 0.00x | 0.00x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -1.87x | -3.07x | -273.40x | - | -40.17x | - | -0.31x | -99.63x | -221.41x | -1.94x | -314.94x | -33.86x |
| Total Equity | 9.66M | 9.66M | 32.82M | 32.05M | 32.7M | 32.91M | 29.47M | 29.38M | 31.09M | 34.3M | 38.72M | 42.74M |
| Equity Growth % | -70.44% | -70.65% | 11.36% | 9.1% | 5.16% | -4.04% | -23.9% | -31.27% | -33.91% | -27.18% | -25.7% | -23.2% |
| Book Value per Share | 2079.62 | 4024.52 | 115.26 | 117.13 | 124.22 | 160.44 | 170.08 | 213.40 | 229.34 | 265.98 | 354.63 | 406.98 |
| Total Shareholders' Equity | 9.72M | 9.71M | 32.77M | 32.01M | 32.65M | 32.86M | 29.41M | 29.32M | 31.02M | 34.21M | 38.6M | 42.6M |
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | -171.17M | -171.08M | -147.53M | -146.23M | -145.15M | -144.69M | -144.28M | -143.62M | -141.22M | -137.45M | -132.63M | -127.59M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -98K | 28.31M | 28.48M | -98K | 29.86M | -98K | -98K | 37.34M | 38.54M | 38.48M | 38.2M | 37.95M |
| Minority Interest | -58K | -55K | 42K | 44K | 48K | 51K | 56K | 61K | 71K | 90K | 121K | 140K |